OKDBVH Stock Overview
Oriola Oyj provides healthcare and wellbeing products primarily in Sweden and Finland.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 2/6 |
Oriola Oyj Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.94 |
| 52 Week High | €1.80 |
| 52 Week Low | €0.94 |
| Beta | 0.62 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | -48.25% |
| 3 Year Change | -49.30% |
| 5 Year Change | -59.87% |
| Change since IPO | -48.64% |
Recent News & Updates
Recent updates
Shareholder Returns
| OKDBVH | GB Healthcare | GB Market | |
|---|---|---|---|
| 7D | 0% | 1.9% | -0.9% |
| 1Y | -48.2% | -29.5% | -1.8% |
Return vs Industry: OKDBVH underperformed the UK Healthcare industry which returned 5.1% over the past year.
Return vs Market: OKDBVH underperformed the UK Market which returned -2.4% over the past year.
Price Volatility
| OKDBVH volatility | |
|---|---|
| OKDBVH Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 7.4% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 11.3% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: OKDBVH has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine OKDBVH's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 754 | Katarina Gabrielson | oriola.com |
Oriola Oyj provides healthcare and wellbeing products in Sweden and Finland. It also offers vitamins, food and food supplements, sports nutrients, wound care, beauty, and makeup related products. The company offers distribution, licensed medicines, and dose dispensing services, as well as involved in research for pharmacies related products.
Oriola Oyj Fundamentals Summary
| OKDBVH fundamental statistics | |
|---|---|
| Market cap | €193.27m |
| Earnings (TTM) | -€26.00m |
| Revenue (TTM) | €1.47b |
0.1x
P/S Ratio-7.2x
P/E RatioIs OKDBVH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OKDBVH income statement (TTM) | |
|---|---|
| Revenue | €1.47b |
| Cost of Revenue | €1.30b |
| Gross Profit | €164.70m |
| Other Expenses | €190.70m |
| Earnings | -€26.00m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Feb 16, 2024
| Earnings per share (EPS) | -0.14 |
| Gross Margin | 11.24% |
| Net Profit Margin | -1.77% |
| Debt/Equity Ratio | 69.4% |
How did OKDBVH perform over the long term?
See historical performance and comparison